SCHEMBL31700994

CC(=O)N[C@H]1[C@H](OC[C@H]2O[C@@H](O[C@H]3[C@H](O)[C@@H](NC(C)=O)[C@H](O[C@H]4[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@H](O)O[C@@H]5CO)[C@@H]4O)O[C@@H]3CO)[C@H](O)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5NC(C)=O)[C@H]4O[C@@H]4O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]4O)[C@H](O)[C@H]3NC(C)=O)[C@H]2O)O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@@H]1O

nearest known ligand 0.54

Predicted protein targets (top 10)

	gene	UniProt	supporting neighbours	confidence
▸	LGALS3	P17931	2/20	0.54

▸	LGALS8	O00214	1/20	0.54

▸	LGALS4	P56470	1/20	0.54

▸	AMY2A	P04746	4/20	0.51

▸	CD209	Q9NNX6	2/20	0.46

▸	ENGASE	Q8NFI3	1/20	0.46

▸	HPSE	Q9Y251	4/20	0.45

▸	CD69	Q07108	1/20	0.44

▸	CHIA	Q9BZP6	1/20	0.44

▸	MAPK1	P28482	1/20	0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31701435	1.00	LGALS3 (0.54)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31700991	1.00	LGALS3 (0.54)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31700307	1.00	LGALS3 (0.54)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31701509	1.00	LGALS3 (0.54)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31701115	0.99	LGALS3 (0.54)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31700152	0.99	LGALS3 (0.54)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31700476	0.99	LGALS3 (0.55)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31700568	0.99	LGALS3 (0.55)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31700939	0.99	LGALS3 (0.55)	LGALS3LGALS8LGALS4AMY2ACD209
SCHEMBL31700944	0.99	LGALS3 (0.55)	LGALS3LGALS8LGALS4AMY2ACD209

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20250319190-A1	APOE LIPOPROTEIN SYSTEMS	KISBEE THERAPEUTICS INC (US)	2025-10-16	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20250319190-A1	APOE LIPOPROTEIN SYSTEMS	APOB, APOL1, LDLR	LGALS3 236/4885LGALS8 242/4885LGALS4 287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.